The lineup of speakers and topics to be discussed is set for a biotech conference in the Queen City that is set for Sept. 14.
“Charlotte’s Emerging Role in Biotechnology 2004” will take place at the Barnhardt Center at the UNC Charlotte Campus. The event is put on by UNC Charlotte’s Office of Technology Transfer, UNC Charlotte College of Information Technology, the Business Innovation & Growth Council, Carolinas, Healthcare System, and the Small Business and Technology Development Center
Speakers and topics include:
Dr. Juan Anguita, UNC Charlotte, on immunosuppression strategies
Dr. Michael Hudson, UNC Charlotte, on use of staph aureus components for enhanced adhesion of bone-forming cells to orthopedic implants
Dr. Thomas Masters of Heineman Medical research Laboratories on angiogenesis and revascularizing of the hear
Dr. Yevette Huet-Hudson of UNC Charlotte on success for in-vitro fertilization
Dr. Nigel Walker, National Institute of Environmental Health Scienes on safety and nanotechnology
Dr. Don deBethizy, president and CEO of Targacept, on the Targacept story
Dr. Larry Mays, UNC Charlotte, on bioinformatics roadmap
Susan Flood, lead strategist at SAS, on the future of bioinformatics
Gahreng Kong, Intersouth Partners, on investment and market trends in biotechnology
John Crumpler, HBM Bio, on a new way to invest in bitotechnology
For more information, see: www.ott.uncc.edu/biotech
